GA
SRNE

GoalVest Advisory’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

GoalVest Advisory’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-32,915
Closed -$11.8K – 442
2023
Q1 		$11.8K Sell
32,915
-18,725
-36% -$6.74K 0.01% 178
2022
Q4 		$45.8K Buy
51,640
+18,025
+54% +$16K 0.03% 113
2022
Q3 		$53K Buy
+33,615
New +$53K 0.04% 109